During the past decade, West China Hospital Of Sichuan University conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "West China Hospital Of Sichuan University" are "Chronic Hepatitis B" (1 trials), "Differentiated Thyroid Cancer" (1 trials) and "Medullary Thyroid Carcinoma" (1 trials). Many other conditions were trialed in "West China Hospital Of Sichuan University" in a lesser frequency.

Most popular intervention types in "West China Hospital Of Sichuan University" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Anlotinib" (2 trials), "Placebo" (2 trials), "Baraclude tablets" (1 trials), "Blank maleate entecavir tablets" (1 trials) and "Entecavir maleate tablets" (1 trials). Other intervention names were less common.

The vast majority of trials in "West China Hospital Of Sichuan University" are 3 trials for "All" genders.

Currently, there are NaN active trials in "West China Hospital Of Sichuan University". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in West China Hospital Of Sichuan University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in West China Hospital Of Sichuan University, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".